Genome Editing Market Size, Share, Growth & Industry Analysis, By Technology (CRISPR, TALEN, ZFN, ANTISENSE, Other Technologies), By Application (Cell Line Engineering, Genetic Engineering, Drug Discovery & Development, Other), By Delivery (Ex-Vivo, In-Vivo), By End User, and Regional Analysis, 2024-2031

TABLE OF CONTENT

1 INTRODUCTION OF THE GLOBAL GENOME EDITING MARKET 
1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Limitations
1.5 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY
3.1 Data Collection
3.1.1 Secondary Sources
3.1.2 Primary Sources
3.1.3 Research Flow
3.2 Subject Matter Expert Advice
3.3 Quality Check
3.4 Final Review
3.5 Bottom-Up Approach
3.6 Top-down Approach

4 GLOBAL GENOME EDITING MARKET OUTLOOK
4.1 Market Evolution
4.2 Overview
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.3.4 Challenges
4.4 Pricing Analysis
4.5 Porter’s Five Forces Analysis
4.6 Value Chain Analysis
4.7 Macroeconomic Analysis

5 IMPACT OF RUSSIA-UKRAINE WAR

6 GLOBAL GENOME EDITING MARKET, BY TECHNOLOGY
6.1 Overview
6.2 CRISPR
6.3 TALEN
6.4 ZFN
6.5 ANTISENSE
6.6 Other Technologies 

7 GLOBAL GENOME EDITING MARKET, BY APPLICATION
7.1 Overview
7.2 Cell Line Engineering
7.3 Genetic Engineering
7.4 Drug Discovery & Development
7.5 Other 

8 GLOBAL GENOME EDITING MARKET, BY DELIVERY
8.1 Overview
8.2 Ex-Vivo
8.3 In-Vivo 

9 GLOBAL GENOME EDITING MARKET, BY END USER
9.1 Overview
9.2 Pharmaceutical & Biotechnology Companies
9.3 Academic & Research Institutes 
9.4 Others

10 GLOBAL GENOME EDITING MARKET, BY GEOGRAPHY
10.1 Overview

11 NORTH AMERICA 
11.1 U.S.
11.2 Canada
11.3 Mexico

12 EUROPE 
12.1 Germany
12.2 U.K.
12.3 France
12.4 Italy
12.5 Spain
12.6 Russia
12.7 Rest of Europe

13 ASIA-PACIFIC 
13.1 China
13.2 Japan
13.3 India
13.4 South Korea
13.5 Rest of Asia-Pacific

14 MIDDLE EAST & AFRICA 
14.1 GCC
14.2 South Africa
14.3 North Africa
14.4 Rest of Middle East & Africa

15 LATIN AMERICA 
15.1 Brazil
15.2 Argentina
15.3 Rest of South America

16  GLOBAL GENOME EDITING MARKET COMPETITIVE LANDSCAPE
16.1 Overview
16.2 Key Developments
16.3 Key Strategic Developments
16.4 Company Market Ranking
16.5 Regional Footprint
16.6 Industry Footprint

17 COMPANY PROFILES
17.1 Merck KGaA
17.1.1 Key Facts
17.1.2 Financial Overview
17.1.3 Product Benchmarking
17.1.4 Recent Developments
17.1.5 Winning Imperatives
17.1.6 Current Focus & Strategies
17.1.7 Threat from competition
17.1.8 SWOT Analysis
17.2 Cibus Inc.
17.2.1 Key Facts
17.2.2 Financial Overview
17.2.3 Product Benchmarking
17.2.4 Recent Developments
17.2.5 Winning Imperatives
17.2.6 Current Focus & Strategies
17.2.7 Threat from competition
17.2.8 SWOT Analysis
17.3 Recombinetics
17.3.1 Key Facts
17.3.2 Financial Overview
17.3.3 Product Benchmarking
17.3.4 Recent Developments
17.3.5 Winning Imperatives
17.3.6 Current Focus & Strategies
17.3.7 Threat from competition
17.3.8 SWOT Analysis
17.4 Sangamo Therapeutics
17.4.1 Key Facts
17.4.2 Financial Overview
17.4.3 Product Benchmarking
17.4.4 Recent Developments
17.4.5 Winning Imperatives
17.4.6 Current Focus & Strategies
17.4.7 Threat from competition
17.4.8 SWOT Analysis
17.5 Editas Medicine
17.5.1 Key Facts
17.5.2 Financial Overview
17.5.3 Product Benchmarking
17.5.4 Recent Developments
17.5.5 Winning Imperatives
17.5.6 Current Focus & Strategies
17.5.7 Threat from competition
17.5.8 SWOT Analysis
17.6 Precision BioSciences
17.6.1 Key Facts
17.6.2 Financial Overview
17.6.3 Product Benchmarking
17.6.4 Recent Developments
17.6.5 Winning Imperatives
17.6.6 Current Focus & Strategies
17.6.7 Threat from competition
17.6.8 SWOT Analysis
17.7 CRISPR Therapeutics
17.7.1 Key Facts
17.7.2 Financial Overview
17.7.3 Product Benchmarking
17.7.4 Recent Developments
17.7.5 Winning Imperatives
17.7.6 Current Focus & Strategies
17.7.7 Threat from competition
17.7.8 SWOT Analysis
17.8 Intellia Therapeutics, Inc.
17.8.1 Key Facts
17.8.2 Financial Overview
17.8.3 Product Benchmarking
17.8.4 Recent Developments
17.8.5 Winning Imperatives
17.8.6 Current Focus & Strategies
17.8.7 Threat from competition
17.8.8 SWOT Analysis
17.9 Caribou Biosciences, Inc
17.9.1 Key Facts
17.9.2 Financial Overview
17.9.3 Product Benchmarking
17.9.4 Recent Developments
17.9.5 Winning Imperatives
17.9.6 Current Focus & Strategies
17.9.7 Threat from competition
17.9.8 SWOT Analysis
17.10 Cellectis S.A.
17.10.1 Key Facts
17.10.2 Financial Overview
17.10.3 Product Benchmarking
17.10.4 Recent Developments
17.10.5 Winning Imperatives
17.10.6 Current Focus & Strategies
17.10.7 Threat from competition
17.10.8 SWOT Analysis

LIST OF TABLES

TABLE 1 Global Genome Editing Market Revenue, By Technology, 2021 – 2031 (USD Billion)
TABLE 2 Global Genome Editing Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 3 Global Genome Editing Market Revenue, By Delivery, 2021 – 2031 (USD Billion)
TABLE 4 Global Genome Editing Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 5 Global Genome Editing Market Revenue, By Geography, 2021 – 2031 (USD Billion)
TABLE 6 North America Genome Editing Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 7 North America Genome Editing Market Revenue, By Technology, 2021 – 2031 (USD Billion)
TABLE 8 North America Genome Editing Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 9 North America Genome Editing Market Revenue, By Delivery, 2021 – 2031 (USD Billion)
TABLE 10 North America Genome Editing Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 11 US Genome Editing Market Revenue, By Technology, 2021 – 2031 (USD Billion)
TABLE 12 US Genome Editing Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 13 US Genome Editing Market Revenue, By Delivery, 2021 – 2031 (USD Billion)
TABLE 14 US Genome Editing Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 15 Canada Genome Editing Market Revenue, By Technology, 2021 – 2031 (USD Billion)
TABLE 16 Canada Genome Editing Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 17 Canada Genome Editing Market Revenue, By Delivery, 2021 – 2031 (USD Billion)
TABLE 18 Canada Genome Editing Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 19 Mexico Genome Editing Market Revenue, By Technology, 2021 – 2031 (USD Billion)
TABLE 20 Mexico Genome Editing Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 21 Mexico Genome Editing Market Revenue, By Delivery, 2021 – 2031 (USD Billion)
TABLE 22 Mexico Genome Editing Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 23 Europe Genome Editing Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 24 Europe Genome Editing Market Revenue, By Technology, 2021 – 2031 (USD Billion)
TABLE 25 Europe Genome Editing Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 26 Europe Genome Editing Market Revenue, By Delivery, 2021 – 2031 (USD Billion)
TABLE 27 Europe Genome Editing Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 28 Germany Genome Editing Market Revenue, By Technology, 2021 – 2031 (USD Billion)
TABLE 29 Germany Genome Editing Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 30 Germany Genome Editing Market Revenue, By Delivery, 2021 – 2031 (USD Billion)
TABLE 31 Germany Genome Editing Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 32 France Genome Editing Market Revenue, By Technology, 2021 – 2031 (USD Billion)
TABLE 33 France Genome Editing Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 34 France Genome Editing Market Revenue, By Delivery, 2021 – 2031 (USD Billion)
TABLE 35 France Genome Editing Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 36 U.K. Genome Editing Market Revenue, By Technology, 2021 – 2031 (USD Billion)
TABLE 37 U.K. Genome Editing Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 38 U.K. Genome Editing Market Revenue, By Delivery, 2021 – 2031 (USD Billion)
TABLE 39 U.K. Genome Editing Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 40 Spain Genome Editing Market Revenue, By Technology, 2021 – 2031 (USD Billion)
TABLE 41 Spain Genome Editing Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 42 Spain Genome Editing Market Revenue, By Delivery, 2021 – 2031 (USD Billion)
TABLE 43 Spain Genome Editing Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 44 Italy Genome Editing Market Revenue, By Technology, 2021 – 2031 (USD Billion)
TABLE 45 Italy Genome Editing Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 46 Italy Genome Editing Market Revenue, By Delivery, 2021 – 2031 (USD Billion)
TABLE 47 Italy Genome Editing Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 48 Russia Genome Editing Market Revenue, By Technology, 2021 – 2031 (USD Billion)
TABLE 49 Russia Genome Editing Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 50 Russia Genome Editing Market Revenue, By Delivery, 2021 – 2031 (USD Billion)
TABLE 51 Russia Genome Editing Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 52 Rest of Europe Genome Editing Market Revenue, By Technology, 2021 – 2031 (USD Billion)
TABLE 53 Rest of Europe Genome Editing Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 54 Rest of Europe Genome Editing Market Revenue, By Delivery, 2021 – 2031 (USD Billion)
TABLE 55 Rest of Europe Genome Editing Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 56 Asia-Pacific Genome Editing Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 57 Asia-Pacific Genome Editing Market Revenue, By Technology, 2021 – 2031 (USD Billion)
TABLE 58 Asia-Pacific Genome Editing Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 59 Asia-Pacific Genome Editing Market Revenue, By Delivery, 2021 – 2031 (USD Billion)
TABLE 60 Asia-Pacific Genome Editing Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 61 China Genome Editing Market Revenue, By Technology, 2021 – 2031 (USD Billion)
TABLE 62 China Genome Editing Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 63 China Genome Editing Market Revenue, By Delivery, 2021 – 2031 (USD Billion)
TABLE 64 China Genome Editing Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 65 Japan Genome Editing Market Revenue, By Technology, 2021 – 2031 (USD Billion)
TABLE 66 Japan Genome Editing Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 67 Japan Genome Editing Market Revenue, By Delivery, 2021 – 2031 (USD Billion)
TABLE 68 Japan Genome Editing Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 69 India Genome Editing Market Revenue, By Technology, 2021 – 2031 (USD Billion)
TABLE 70 India Genome Editing Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 71 India Genome Editing Market Revenue, By Delivery, 2021 – 2031 (USD Billion)
TABLE 72 India Genome Editing Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 73 South Korea Genome Editing Market Revenue, By Technology, 2021 – 2031 (USD Billion)
TABLE 74 South Korea Genome Editing Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 75 South Korea Genome Editing Market Revenue, By Delivery, 2021 – 2031 (USD Billion)
TABLE 76 South Korea Genome Editing Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 77 Rest of Asia-Pacific Genome Editing Market Revenue, By Technology, 2021 – 2031 (USD Billion)
TABLE 78 Rest of Asia-Pacific Genome Editing Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 79 Rest of Asia-Pacific Genome Editing Market Revenue, By Delivery, 2021 – 2031 (USD Billion)
TABLE 80 Rest of Asia-Pacific Genome Editing Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 81 Middle East and Africa Genome Editing Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 82 Middle East and Africa Genome Editing Market Revenue, By Technology, 2021 – 2031 (USD Billion)
TABLE 83 Middle East and Africa Genome Editing Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 84 Middle East and Africa Genome Editing Market Revenue, By Delivery, 2021 – 2031 (USD Billion)
TABLE 85 Middle East and Africa Genome Editing Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 86 GCC Genome Editing Market Revenue, By Technology, 2021 – 2031 (USD Billion)
TABLE 87 GCC Genome Editing Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 88 GCC Genome Editing Market Revenue, By Delivery, 2021 – 2031 (USD Billion)
TABLE 89 GCC Genome Editing Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 90 North Africa Genome Editing Market Revenue, By Technology, 2021 – 2031 (USD Billion)
TABLE 91 North Africa Genome Editing Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 92 North Africa Genome Editing Market Revenue, By Delivery, 2021 – 2031 (USD Billion)
TABLE 93 North Africa Genome Editing Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 94 South Africa Genome Editing Market Revenue, By Technology, 2021 – 2031 (USD Billion)
TABLE 95 South Africa Genome Editing Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 96 South Africa Genome Editing Market Revenue, By Delivery, 2021 – 2031 (USD Billion)
TABLE 97 South Africa Genome Editing Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 98 Rest of Middle East & Africa Genome Editing Market Revenue, By Technology, 2021 – 2031 (USD Billion)
TABLE 99 Rest of Middle East & Africa Genome Editing Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 100 Rest of Middle East & Africa Genome Editing Market Revenue, By Delivery, 2021 – 2031 (USD Billion)
TABLE 101 Rest of Middle East & Africa Genome Editing Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 102 Latin America Genome Editing Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 103 Latin America Genome Editing Market Revenue, By Technology, 2021 – 2031 (USD Billion)
TABLE 104 Latin America Genome Editing Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 105 Latin America Genome Editing Market Revenue, By Delivery, 2021 – 2031 (USD Billion)
TABLE 106 Latin America Genome Editing Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 107 Brazil Genome Editing Market Revenue, By Technology, 2021 – 2031 (USD Billion)
TABLE 108 Brazil Genome Editing Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 109 Brazil Genome Editing Market Revenue, By Delivery, 2021 – 2031 (USD Billion)
TABLE 110 Brazil Genome Editing Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 111 Argentina Genome Editing Market Revenue, By Technology, 2021 – 2031 (USD Billion)
TABLE 112 Argentina Genome Editing Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 113 Argentina Genome Editing Market Revenue, By Delivery, 2021 – 2031 (USD Billion)
TABLE 114 Argentina Genome Editing Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 115 Rest of Latin America Genome Editing Market Revenue, By Technology, 2021 – 2031 (USD Billion)
TABLE 116 Rest of Latin America Genome Editing Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 117 Rest of Latin America Genome Editing Market Revenue, By Delivery, 2021 – 2031 (USD Billion)
TABLE 118 Rest of Latin America Genome Editing Market Revenue, By End User, 2021 – 2031 (USD Billion)
TABLE 119 Company Market Ranking
TABLE 120 Regional Footprint
TABLE 121 Product Benchmarking
TABLE 122 Recent Developments
TABLE 123 Winning Imperatives 

LIST OF FIGURES

FIG. 1 Market Segmentation
FIG. 2 Research Timeline
FIG. 3 Global Genome Editing Market 2021-2031 (USD Billion)
FIG. 4 Global Genome Editing Market Geographical Analysis (CAGR %)
FIG. 5 Global Genome Editing Absolute Market Opportunity (USD Billion)
FIG. 6 Global Genome Editing Market Attractiveness (USD Billion)
FIG. 7 Global Genome Editing Market, By Technology, 2021-2031 (USD Billion)
FIG. 8 Global Genome Editing Market, By Application, 2021-2031 (USD Billion)
FIG. 9 Global Genome Editing Market, By Delivery, 2021-2031 (USD Billion)
FIG. 10 Global Genome Editing Market, By End User, 2021-2031 (USD Billion)
FIG. 11 Research Methodology
FIG. 12 Research Process
FIG. 13 Bottom-Up Approach
FIG. 14 Top-Bottom Approach
FIG. 15 Market Dynamics Overview
FIG. 16 Porter's Five Forces Analysis
FIG. 17 Value Chain Analysis
FIG. 18 Macroeconomic Analysis
FIG. 19 Global Genome Editing Market Revenue Share, By Technology, 2023 and 2031 (%)
FIG. 20 Global Genome Editing Market Revenue Share, By Application, 2023 and 2031 (%)
FIG. 21 Global Genome Editing Market Revenue Share, By Delivery, 2023 and 2031 (%)
FIG. 22 Global Genome Editing Market Revenue Share, By End User, 2023 and 2031 (%)
FIG. 23 Global Genome Editing Market Revenue Share, By Geographic Regions, 2023 and 2031 (%)
FIG. 24 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 25 North America Genome Editing Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 26 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 27 Europe Genome Editing Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 28 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 29 Asia-Pacific Genome Editing Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 30 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 31 Middle East & Africa Genome Editing Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 32 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 33 Latin America Genome Editing Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 34 Key Strategic Development
FIG. 35 Key Facts
FIG. 36 Financial Overview
FIG. 37 SWOT Analysis